Role of HMGB1 in cardiovascular diseases
- 17 February 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 6 (2), 130-135
- https://doi.org/10.1016/j.coph.2005.10.010
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- All teas are not created equalInternational Journal of Cardiology, 2006
- More tea for septic patients? – Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokinesMedical Hypotheses, 2005
- INTERFERON-γ INHIBITION ATTENUATES LETHALITY AFTER CECAL LIGATION AND PUNCTURE IN RATS: IMPLICATION OF HIGH MOBILITY GROUP BOX-1Shock, 2005
- Cytokines and cardiovascular diseaseJournal of Leukocyte Biology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High‐Mobility Group Box Chromosomal Protein 1Scandinavian Journal of Immunology, 2004
- Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanismsJournal of Leukocyte Biology, 2004
- Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemiaThe Journal of Thoracic and Cardiovascular Surgery, 2004
- High mobility group 1 B‐box mediates activation of human endotheliumJournal of Internal Medicine, 2003
- Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary AtherosclerosisThe American Journal of Pathology, 2001